Rebecca Zash

机构：Beth Israel Deaconess Medical Center, Harvard University, Botswana Harvard AIDS Institute Partnership · ORCID：0000-0001-5707-421X

发表论文 96 篇 · 总被引 3762 次 · h-index 28

代表论文

• Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial (2024 · Nature Medicine · 被引 61)
• Risk of COVID-19 after natural infection or vaccination (2023 · EBioMedicine · 被引 14)
• Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum (2024 · Clinical Infectious Diseases · 被引 12)
• Metabolic implications and safety of dolutegravir use in pregnancy (2023 · The Lancet HIV · 被引 12)
• Neonatal mortality risk of vulnerable newborns by fine stratum of gestational age and birthweight for 230 679 live births in nine low‐ and middle‐income countries, 2000–2017 (2024 · BJOG An International Journal of Obstetrics & Gynaecology · 被引 11)
• A qualitative assessment of barriers to iron and folic acid supplementation among pregnant women in Botswana (2024 · BMC Public Health · 被引 9)